Overview

Detailed Summary

HVAX Technologies Limited specializes in providing turnkey cleanroom and controlled environment infrastructure solutions aimed at the pharmaceutical, healthcare, hospital, and biotech sectors.
The company is expanding into the healthcare infrastructure segment with a proposed acquisition of Krew Instruments, which aligns with HVAX's vision to diversify its portfolio.
HVAX shows strong growth momentum with a current order book of INR350 crores and a pipeline worth INR650 crores, showcasing its ability to convert opportunities into financial successes.
Their strategy involves expanding operations through strategic partnerships and acquisitions, enhancing capabilities and establishing footholds in the healthcare market.
HVAX anticipates a revenue growth of 35% year-on-year, driven by strategic expansions, operational efficiency, and a robust order pipeline in pharmaceuticals and emerging sectors.

Sector: Construction
Industry: Civil Construction
Market Cap: 218 Cr
Volatility: Low Risk
P/E Ratio: 17.1
Industry P/E: 25.0
PEG Ratio: 0.4
P/B Ratio: 3.0
52W High: 1,029.30
52W Low: 565.00

Sales CAGR

1Y: 23.54%
3Y: 24.28%
5Y: 22.81%
10Y: —

Profit CAGR

1Y: 29.58%
3Y: 38.23%
5Y: 42.11%
10Y: —

ROE

TTM: 15.78%
3Y: 20.60%
5Y: 22.93%
10Y: —

ROCE

TTM: 19.74%
3Y: 29.46%
5Y: 31.29%
10Y: —

Technicals

‌

Forecasts

Peers

Industrials Construction Construction Civil Construction

Symbol	Watchlist	Price	Market Cap	P/E	P/B	Div Yield (%)	ROE (%)	ROCE (%)	ROA (%)
VISAMAN		122.75	246 Cr	73.95	3.75	0.00	5.24	7.42	2.55
MADHAVIPL		8.00	245 Cr	7.77	1.05	0.00	15.00	16.10	4.62
CURRENT		125.00	230 Cr	17.86	3.33	0.00	13.50	15.64	8.94
HVAX		786.00	218 Cr	17.12	3.03	0.00	15.78	19.74	10.88
SAB		133.35	203 Cr	272.14	0.48	0.00	1.00	1.88	-0.42
KARBON		139.90	199 Cr	10.95	1.83	0.00	13.61	20.09	5.61
AGARWALTUF		102.05	195 Cr	11.89	2.07	0.00	20.18	23.59	15.97
Median: 7 Co.	—	125.00	218 Cr	17.12	2.07	0.00	13.61	16.10	5.61

Financial Statements

AI Powered Summary

Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.

Ask AI

Standalone Half Yearly Results (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Sep 2023	Mar 2024	Sep 2024	Mar 2025	Sep 2025
Sales	29	77	46	85	61
Expenses	26	67	39	73	54
Interest	0.62	0.96	1.09	1.39	1.26
Operating Profit	2.96	10	7.05	12	6.37
OPM %	10.25	13.03	15.20	13.63	10.51
Other Income	0.06	0.99	0.11	0.28	2.16
Depreciation	0.98	0.10	0.84	0.71	0.67
Profit Before Tax	1.43	9.99	5.23	9.73	6.61
Tax %	25.17	25.43	26.96	25.80	25.42
Net Profit	1.07	7.45	3.83	7.22	4.92
EPS in Rs	—	—	—	—	—

Standalone Profit Loss (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Sales	47	61	68	96	106	131
Expenses	41	55	61	87	92	112
Operating Profit	5.73	5.43	6.89	8.56	14	19
OPM %	12.21	8.93	10.09	8.92	13.04	14.18
Other Income	1.02	1.08	0.53	0.21	1.41	0.39
Interest	1.26	0.56	0.63	0.70	1.58	2.47
Depreciation	0.41	0.71	1.22	1.07	1.07	1.54
Profit Before Tax	2.55	5.24	5.58	6.99	13	15
Tax %	25.30	28.94	25.04	25.56	25.39	26.18
Net Profit	1.91	3.72	4.18	5.20	9.39	11
EPS in Rs	—	—	—	—	—	—
Dividend Payout %	0.00	0.00	0.00	0.00	0.00	0.00

Standalone Balance Sheet (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	0.62	0.62	0.62	0.62	0.68	2.78
Reserves	5.11	8.59	11	17	30	69
Borrowings	9.25	5.21	10	17	24	28
Other Liabilities	13	23	32	44	8.69	22
Total Liabilities	28	38	54	78	64	122
Fixed Assets	7.23	10	8.04	7.06	8.98	7.76
CWIP	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.53	0.85	0.41	0.72	0.37	0.03
Other Assets	20	26	45	70	54	114
Total Assets	28	38	54	78	64	122

Standalone Cash Flows (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity	1.87	6.29	-0.84	-3.62	-12	-22
Cash from Investing Activity	-0.57	-3.98	1.70	-0.23	-1.68	0.41
Cash from Financing Activity	-0.97	-2.82	2.49	6.12	9.87	31
Net Cash Flow	0.32	-0.51	3.34	2.26	-4.04	9.60

Shareholdings

Shareholding History

Quarterly

Yearly

Quarterly

	Jun 2024	Oct 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Promoters	90.50%	66.65%	66.65%	66.65%	66.65%	66.65%	66.65%
FIIs	0.00%	9.37%	9.34%	9.29%	9.17%	9.13%	8.96%
DIIs	9.50%	0.56%	0.41%	0.70%	1.13%	1.08%	1.08%
Public	0.00%	23.42%	23.60%	23.36%	23.05%	23.14%	23.31%
Total Shareholders	10	1,100	535	508	463	448	428

Market Transactions

Unlock more with professional

Real-time bulk & block deal transactions
Export transaction data for analysis

Projection

Documents

Presentations

Concalls

Reports

Presentations

Investor Presentation

Q4 FY25

Actions

Action Type

‌
‌

Announcements

Last 7 days

Newest

Sentiment

Sorry, no results found!

AI Mode

Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.

Ask AI

Frequently Asked Questions about HVAX Technologies Ltd

HVAX Technologies Ltd (HVAX) is currently trading at 809.90 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

HVAX Technologies Limited specializes in providing turnkey cleanroom and controlled environment infrastructure solutions aimed at the pharmaceutical, healthcare, hospital, and biotech sectors. The company is expanding into the healthcare infrastructure segment with a proposed acquisition of Krew Instruments, which aligns with HVAX's vision to diversify its portfolio. HVAX shows strong growth momentum with a current order book of INR350 crores and a pipeline worth INR650 crores, showcasing its ability to convert opportunities into financial successes. Their strategy involves expanding operations through strategic partnerships and acquisitions, enhancing capabilities and establishing footholds in the healthcare market. HVAX anticipates a revenue growth of 35% year-on-year, driven by strategic expansions, operational efficiency, and a robust order pipeline in pharmaceuticals and emerging sectors.

Over the past 52 weeks, HVAX Technologies Ltd has traded between a low of ₹565.00 and a high of ₹1,029.30. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

HVAX Technologies Ltd has a market capitalization of approximately 218.26. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

HVAX Technologies Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 17.12 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 218.26 Cr, HVAX Technologies Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

HVAX Technologies Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of HVAX Technologies Ltd is 17.12. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

Hvax Technologies Ltd

Stock Summary and Key Metrics

Investment Checklist

Investment Checklist

Overview

Financial Ratios

Technicals

Forecasts

Peers

Price Chart Comparison